Nine27 Capital Management, LP's SEC 13F Portfolio (—)
Nine27 Capital Management, LP
CIK: 0001878063
Long-term holder
Total reported value
—
Reporting period: 2023-12-31 · Number of holdings: 1
Nine27 Capital Management, LP disclosed 1 holdings in its latest 13F filing for the period ending 2023-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Position changes disclosed by Nine27 Capital Management, LP for the quarter ending 2023-12-31, including ticker, issuer, weight change, shares change, and action
What is Nine27 Capital Management, LP and what type of investor is it?
Nine27 Capital Management, LP is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Nine27 Capital Management, LP's largest equity positions?
Based on the latest 13F filing, Nine27 Capital Management, LP's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Nine27 Capital Management, LP make in its most recent portfolio filing?
No notable portfolio changes were recorded for Nine27 Capital Management, LP in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Nine27 Capital Management, LP focus on?
Sector breakdown data is not yet available for Nine27 Capital Management, LP. Check back after the next 13F processing cycle.